Publications by authors named "Gilberto de Castro"

Claim this Profile
P
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study.
Makoto Tahara, Richard Greil, Danny Rischin, Kevin J Harrington, Barbara Burtness, Gilberto de Castro

Eur J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials.
Benjamin J Solomon, Daniel S W Tan, Gilberto de Castro, Manuel Cobo, Marina Chiara Garassino

Cancer Res Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab in Patients with Metastatic Castration-Resistant Prostate Cancer with and without DNA Repair Defects.
Pedro Isaacsson Velho, Diogo Assed Bastos, Pedro Tofani Saint'ana, Brenda Rigatti, Emily Tonin da Costa, Gilberto de Castro

Clin Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study.
Martin Reck, Rafal Dziadziuszko, Shunichi Sugawara, Steven Kao, Maximilian Hochmair, Gilberto de Castro

Lung Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial.
Marcin Dzienis, Juan Cundom, Christian Sebastian Fuentes, Anna Spreafico, Melanie Nordlinger, Gilberto de Castro

J Clin Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Services Access Inequalities in Brazil Result in Poorer Outcomes for Stage III NSCLC-RELANCE/LACOG 0118.
Vladmir C Cordeiro de Lima, Ana Gelatti, José F P Moura, Aline F Fares, Gilberto de Castro

JTO Clin Res Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.
Daniel S W Tan, Enriqueta Felip, Gilberto de Castro, Benjamin J Solomon, Alastair Greystoke

J Clin Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Multidisciplinary Team Management Improve Clinical Outcomes in NSCLC? A Systematic Review With Meta-Analysis.
Gilberto de Castro, Fabiano Hahn Souza, Júlia Lima, Luis Pedro Bernardi, Carlos Henrique Andrade Teixeira

JTO Clin Res Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased sympathetic nervous system impairs prognosis in lung cancer patients: a scoping review of clinical studies.
Fabrício T Garramona, Telma F Cunha, Janaína S Vieira, Gabriela Borges, Gabriela Santos, Gilberto de Castro

Lung Cancer Manag· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinical and Molecular Profile of Lung Cancer Patients Harboring the R337H Germline Variant in a Brazilian Cancer Center: The Possible Mechanism of Carcinogenesis.
Carlos D H Lopes, Fernanda F Antonacio, Priscila M G Moraes, Paula F Asprino, Pedro A F Galante, Gilberto de Castro

Int J Mol Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study.
Gilberto de Castro, Iveta Kudaba, Yi-Long Wu, Gilberto Lopes, Dariusz M Kowalski

J Clin Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NEPTUNE China cohort: First-line durvalumab plus tremelimumab in Chinese patients with metastatic non-small-cell lung cancer.
Ying Cheng, Qing Zhou, Baohui Han, Yun Fan, Li Shan, Gilberto de Castro

Lung Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing NFκB and HDAC inhibitors to individually target cancer stem cells and non-cancer stem cells from mucoepidermoid carcinomas.
Luan César Silva, Gabriell Bonifácio Borgato, Vivian Petersen Wagner, Manoela Domingues Martins, Márcio Ajudarte Lopes, Gilberto De Castro

Am J Cancer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting survival in metastatic non-small cell lung cancer patients with poor ECOG-PS: A single-arm prospective study.
Mateus Trinconi Cunha, Ana Paula de Souza Borges, Vinicius Carvalho Jardim, André Fujita, Gilberto de Castro

Cancer Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.
Kevin J Harrington, Barbara Burtness, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro

J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC.
Gilberto de Castro, Naiyer A Rizvi, Peter Schmid, Konstantinos Syrigos, Claudio Martin

J Thorac Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of first-line nivolumab in patients with locally advanced or metastatic cutaneous squamous-cell carcinoma.
Rodrigo R Munhoz, Guilherme Nader-Marta, Veridiana P de Camargo, Marcello M Queiroz, Jade Cury-Martins, Gilberto de Castro

Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Oncologists' Attitudes Concerning Comprehensive Genomic Profiling in Stage IV Lung Adenocarcinoma in Brazil.
Aline F Fares, Pedro H Martinez, Pedro H Farina, Isaac Bicalho de Souza, Daniel V Araújo, Gilberto de Castro

JTO Clin Res Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score.
Barbara Burtness, Danny Rischin, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro

J Clin Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
Danny Rischin, Kevin J Harrington, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro

Oral Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial.
Elisa Kauark-Fontes, Cesar Augusto Migliorati, Joel B Epstein, Nathaniel Simon Treister, Carolina Guimarães Bonfim Alves, Gilberto de Castro

Support Care Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cushing's syndrome due to ectopic adrenocorticotropin secretion by a parotid carcinoma.
Fernanda F Antonacio, Guilherme Harada, Rafael S Vilela, Thais C Freitas, Jose V Lima, Gilberto de Castro

Arch Endocrinol Metab· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Small-Cell Lung Cancer With CNS Metastasis: Disparities From a Real-World Analysis (GBOT-LACOG 0417).
Juliano Cé Coelho, Giselle de Souza Carvalho, Fabio Chaves, Pedro de Marchi, Gilberto de Castro

JCO Glob Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of a supervised group exercise intervention combined with active lifestyle recommendations on breast cancer survivors' health, physical functioning, and quality of life indices: study protocol for a randomized and controlled trial.
Luiz Augusto Riani Costa, Raphael F Barreto, Sarah Milani Moraes de Leandrini, Aline Rachel Bezerra Gurgel, Gabriel Toledo de Sales, Gilberto de Castro

Trials· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1-Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042.
Aaron S Mansfield, Roy S Herbst, Gilberto de Castro, Rina Hui, Nir Peled

JTO Clin Res Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis